Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

ZB 06

Next Previous
Drug Profile

ZB 06

Alternative Names: KB-15 A; ZB-06

Latest Information Update: 05 Nov 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator ZabBio
  • Developer Eastern Virginia Medical School; ZabBio
  • Class Alcohols; Monoclonal antibodies; Polyvinyls; Spermicidal contraceptives
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Pregnancy

Most Recent Events

  • 29 Oct 2025 ZabBio plans a phase-I pharmacokinetics trial (In volunteers) in January 2026 (Vaginal, Films) (NCT07222020),
  • 13 Jun 2024 ZB 06 is still in phase I trials for Pregnancy in USA (KBio pipeline, June 2024)
  • 13 Jun 2024 KBio plans a phase IIa trial for Pregnancy (KBio Pipeline, June 2024)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top